INTRODUCTION
============

Post-translational proteolytic cleavage of precursors of membrane fusion glycoprotein hemagglutinin (HA~0~) of the enveloped influenza A virus (IAV) is a prerequisite for viral membrane fusion activity and virus entry into the cell ([@B10]; [@B32]; [@B21]; [@B13]). However, IAV has no HA~0~ processing protease in its genes. Thus, cellular proteolytic conversion of HA~0~ to HA~1~ and HA~2~ subunits is indispensable for viral entry and multiplication within the infected host, and is a major determinant of IAV pathogenicity.

To-date, two main HA~0~ processing motifs have been described in IAV. One is the single basic HA~0~ processing motif Q(E)-T/X-R sequence of human seasonal IAVs ([@B20]; [@B13]), and the R-E-T-R and P-K-X-R motifs of avirulent avian IAV H5 and H7, respectively ([@B39]), which are readily cleaved by several extracellular trypsin-type proteases. Among many of the cellular trypsin-type serine proteases, only few enzymes selectively convert HA~0~ to HA~1~ and HA~2~. In addition, the processing proteases for the single basic motif are predominantly distributed in the airway and enteric duct, and most of the epidemic human IAV known to date are pneumotropic in which the virus proliferates in these organs, except for a few neurotropic strains, such as IAV WSN/33(H1N1) strain ([@B43]). The other HA~0~ processing motif is a multiple-basic-residues motif of the highly pathogenic avian influenza (HPAI) viruses. In the multiple basic residues motifs, the R-K/R-K/R/X-R motif with R at position P4 is readily cleaved by ubiquitously present intracellular processing proteases, such as furin and proprotein convertases (PCs)5/6, in the presence of calcium ([@B20]; [@B11]; [@B30]). However, replacement of P4 R by K and a non-basic amino acid in the multi-basic motif significantly suppresses the processing activities of furin and PCs ([@B2]; [@B37]; [@B30]). We recently reported the identification of novel type II membrane processing proteases of the cell surface, which preferentially cleaved after the carboxy-terminal R residue in the multiple basic residues motifs of both R-K/R-K/R/X-R and K-K/R-K/R/X-R sequences without calcium.

In the progress of IAV pathogenicity, infection results in up-regulation of host cellular proteases, such as latent ectopic pancreatic trypsin and matrix metalloprotease-9 (MMP-9) in various organs, potentially causing damage of connective tissues and destruction of tight junctions of endothelial cells followed by severe edema.

HA~0~ PROCESSING PROTEASES IN THE AIRWAY FOR HUMAN SEASONAL INFLUENZA VIRUSES
=============================================================================

[Figure 1](#F1){ref-type="fig"} shows the detection of mouse-adapted IAV Aich/2/68(H3N2) antigen in airway epithelial cells of mice at 2 and 6 days after intranasal infection. The viral antigen was initially detected on the cilia of airway epithelial cells at day 2 after infection (typically \>90% of infected cells were ciliated airway epithelial cells in the mouse bronchus) ([Figure 1](#F1){ref-type="fig"}A). Along with the spread of virus infection at day 6, the virus antigen spread from the ciliated epithelial cells to neighboring non-ciliated secretory epithelial cells in the bronchus and was detectable in the whole cell but sparing the nucleus ([Figure 1](#F1){ref-type="fig"}B). The comb-like structure of epithelial cells cilia became swollen, forming fused-structures at day 6 after viral infection ([Figure 1](#F1){ref-type="fig"}C and 1D), which subsequently fell off.

![Immunofluorescence detection of mouse-adapted human IAV Aichi/2/68(H3N2) *in vivo* after infection of mice for 2 days (A) and 6 days (B). C57BL/6 female mice weighing 10-12 g were instilled intranasally with 6.6 × 10^4^ PFU of mouse-adapted human IAV. Two and 6 days after infection, mouse bronchi were isolated, fixed and immunostained for virus HA antigen (green). C and D: Scanning electron micrographs of the surface of bronchus of mice before (C) and (D) 6 days after IAV infection. Cilia of airway epithelial cells of female mouse with a comb-like structure before virus infection became swollen, forming fused-structures at 6 days after intranasal IAV infection and many of such cilia subsequently fell off. Bar = 1 μm.](jmgm-03-167-g001){#F1}

The HA~0~ processing proteases reported for human IAV in animals and humans that recognize single basic motif are pancreatic trypsin ([@B19]), plasmin from calf and chicken serum ([@B22]), blood clotting factor Xa from chick embryo ([@B9]), tryptase Clara from rat lungs ([@B16]), mini-plasmin from rat lungs ([@B25]), ectopic anionic trypsin from rat lungs ([@B38]), porcine mast cell tryptase ([@B6]), tryptase TC30 from porcine lungs ([@B31]) and transmembrane protease serine (TMPRSS) 2 and type II membrane protein human airway trypsin-like protease (HAT) ([@B5]) ([Table 1](#T1){ref-type="table"}). Why various trypsin-type HA~0~ processing proteases capable of potentiating IAV infections exist in the airways? We found different distribution for these cellular proteases in the airways ([@B15]) as well as different proteolytic potentiation of various strains of the viruses ([@B25]). Among the proteases we have examined, trypsin efficiently activated the infectivity of all strains. Mini- and micro-plasmin activated almost all strains, though less efficiently than trypsin. Different HA cleavability of some of the processing proteases was found among species: mast cell tryptase from porcine lungs processed HA~0~, whereas human and rat mast cell tryptase did not ([@B6]). However, among the reported proteases, blood clotting factor Xa from human serum, not from chick embryo, hardly cleaved HA~0~ of IAV Aich/2/68(H3N2) without loss of their amidolytic activities against synthetic peptide substrates (Kido H et al, unpublished data). In addition to the host cellular proteases, microbial proteases also proteolytically activate influenza virus HA~0~ in bacterial infection of the airways and may play a role in the spread of the virus ([@B36]; [@B1]). Mutational evolution of IAV HA~0~ to adapt to these host trypsin-type processing proteases in the airway allows efficient multiplication of the virus *in vivo* which ultimately increase to becomes epidemic.

HA~0~ PROCESSING PROTEASES FOR THE HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUSES
============================================================================

To-date, all HPAI viruses of H5 and H7 subtypes have cleavage site motifs with multiple basic amino acids ([@B46]; [@B39]) and HA~0~ of HPAI virus is postulated to be cleaved by ubiquitous proteases, such as subtilisin-like proteases, furin and PC5/6 ([@B20]). In this review, we add a new member of type II membrane serine proteases on the cell surface, other than the subtilisin-like proteases in the *trans*-Golgi network, which recognize and cleave HA~0~ of HPAI viruses with the multiple basic motifs of both R-K/R-(K/R/X)-R sequence with R at position P4 and K-K/R-(K/R/X)-R sequence with K at position P4.

###### 

Comparison of viral activating enzymes

  Enzyme                          MW (kDa) SDS-PAGE   MW (kDa) Non-reducing condition (composition)   Optimal substrate   Inhibitor                                         Localization                                                               Reference
  ------------------------------- ------------------- ----------------------------------------------- ------------------- ------------------------------------------------- -------------------------------------------------------------------------- ----------------------
  **Tryptase Clara**              30                  180 (hexamer)                                   QAR                 aprotinin, leupeptin, antipain, KSTI              bronchiolar epithelial Clara cells                                         [@B16]
  **Mini-plasmin**                28 + 12             38 (heterodimer)                                QAR                 aprotinin, KSTI, BBSTI, leupeptin                 folded epithelial cells in bronchiolar divisions                           [@B25]
  **Ectopic anionic trypsin I**   22                  31 (monomer)                                    EGR QGR             aprotinin, soybean trypsin inhibitor, leupeptin   stromal cells in peri-bronchiolar region                                   [@B38]
  **Mast cell tryptase**          32-35               120 (tetramer)                                  QAR                 antipain, leupeptin                               mast cells                                                                 [@B6]
  **Tryptase TC30**               30                  30 (monomer)                                    SIQSR               aprotinin, benzamidine, leupeptin                 ND                                                                         [@B31]
  **HAT**                         28                  28 (monomer)                                    FSR                 aprotinin, leupeptin, antipain, KSTI              ciliated epithelial cells                                                  Yasuoka et al., 1997
  **TMPRSS2**                     70 (32)             70 (32 kDa: released form) (monomer)            GGR                 Benzyloxycarbonyl lysine dephenylphosphonate      Epithelial cells of respiratory, gastrointestinal, and urogenital tracts   Wilson et al., 2005

HAT: type II membrane protein human airway trypsin-like protease; TMPRSS2: transmembrane protease serine 2; M.W.: molecular weight, KSTI; Kunitz-type soybean trypsin inhibitor; BBSTI: Bowman-Birk soybean trypsin inhibitor; ND: Not determined.

The cleavage preferences of subtilisin-like proteases, furin, PC4, PC5/6, PC7, PACE4, are R at P1 and P4 positions in the cleavage motif R-X-(R/K/X)-R and replacement of P4 R by K and a nonbasic amino acid significantly suppresses their processing activity ([@B4]; [@B2]; [@B37]; [@B30]). These subtilisin-like proteases are calcium-dependent with a pH optimum ranging from 6.5 to 7.5 ([@B34]) and are mainly localized intracellularly in the *trans*-Golgi network and some cycle between the *trans*-Golgi and the cell surface membrane ([@B37]). The relationship between the pathogenesis of HPAI viruses and proteolytic HA~0~ cleavage of the multiple basic residue motif with R at P1 and P4 positions has been studied extensively (see reviews by [@B46]; [@B34]; [@B41]; [@B33]). In the HPAI viruses, however, there is another type of HA~0~ cleavage sequence with multi-basic cleavage motif with R at P1 and K at P4, which is not a preferable or not a substrate of furin.

Type II membrane serine proteases (TTSP) of mosaic serine protease large form (MSPL) and its splice variant transmembrane protease serine 13 (TMPRSS13) with a pH optimum ranging from 7.0 to 8.5 and no calcium requirement, are identified as new candidate HA~0~ processing proteases for HAPI virus on the cell surface. MSPL and TMPRSS13 were recently cloned from human lungs ([@B17]; [@B14]). Although furin selectively cleaves the multiple basic residues motif with R at P1 and P4, these novel membrane proteases preferentially recognize the double basic residues at the cleavage site, and R or K at P4 position in the multiple basic residues motifs greatly enhances the efficiency of processing.

[Figure 2](#F2){ref-type="fig"} shows alignment of the amino acid sequences of MSPL with 581 residues and TMPRSS13 with 567 residues and schematic representation of the domain structure of MSPL. The serine protease domains at residues 321--581 for MSPL and 326--567 for TMPRSS13 are identical except for the C-terminal ends, *i.e.*, 555--581 for MSPL and 560--567 for TMPRSS13 ([Figure 2](#F2){ref-type="fig"}A). They have a typical catalytic triad (His, Asp and Ser) of serine proteases, and a putative proteolytic activation site (R) in the R^320^-I-V-G-G^324^ in MSPL and R^325^-I-V-G-G^329^ in TMPRSS13. The consensus protease domain of MSPL/TMPRSS13 exhibits 42, 39 and 43% identity with those of human plasma kallikrein ([@B3]), hepsin ([@B40]), and transmembrane protease serine 2 (TMPRSS2) ([@B29]), respectively, but poor identity with subtilisin family protease furin. MSPL and TMPRSS13 have putative transmembrane domains (P^162^--W^184^ and P^167^--W^189^, respectively) at the N-terminal sides. The cytoplasmic domain of these variants has tandem repeat motifs corresponding to the phosphorylation sites of cyclin-dependent kinase Cdc2, CaM kinase II and protein kinase C ([@B12]; [@B42]), and is the longest among the TTSPs known to date ([Figure 2](#F2){ref-type="fig"}B).

![Alignment of amino acid sequences of hMSPL and hTMPRSS13 and schematic representation of the domain structures of hMSPL. (A) Alignment of the amino acid sequences of hMSPL and hTMPRSS13. Numbering starts with Met^1^ of the first amino acid. The putative transmembrane domain is bold-underlined. Arrow points to the putative cleavage site for active serine protease. The catalytic triad (His, Asp and Ser) are indicated by arrowheads. Potential *N*-glycosylation sites are indicated by closed diamonds. hTMPRSS13 differs from hMSPL by the 5-amino acid insertion in the tandem repeat sequences (from Gln^83^ to Ala^87^) and the 8-amino acid extension at the C-terminus (from Ser^560^ to Ser^567^) (asterisks). (B) Schematic representation of predicted domain structure of hMSPL. TM, transmembrane domain; SRCR, scavenger receptor cysteine-rich domain; SPD, serine protease domain. The putative kinase phosphorylation sites found in the N-terminal side tandem repeat sequence. The sequence motifs matching the consensus sequences, such as S/T-P-X-K/R of Cdc2, R-X-X-S/T of CaM kinase II and R-X-X-S-X-R of protein kinase C, are in boldface. Homologous sequences, ASPA, are underlined.](jmgm-03-167-g002){#F2}

The expression profiles of MSPL and TMPRSS13 in various human tissues and cells assessed by reverse transcription-polymerase chain reaction (RT-PCR) with specific primer pairs for each C-terminal of the serine protease domains ([Figure 3](#F3){ref-type="fig"}A and B), show that both genes are predominantly expressed in human lung, placenta, pancreas and prostate, although TMPRSS13 is almost ubiquitously expressed in various organs except a limited expression in skeletal muscle. TMPRSS13/MSPL are expressed at high levels in blood vessels, human choriocarcinoma (BeWo) cells and human umbilical vein endothelial cells (HUVEC) in primary cultures, but not detectable in human endothelial cell line ECV-304, although furin is detectable in almost all human organs and the cells examined, including ECV-304 (data not shown). The high expression of chicken TMPRSS13 (cTMPRSS13) is also detected in blood vessels, lungs, trachea, colon, small intestines and kidneys ([Figure 3](#F3){ref-type="fig"}C).

![Gene expression profiles of hMSPL and hTMPRSS13 in various human tissues (A), cells (B) and those of cTMPRSS13 (C). RT-PCR analysis was carried out using MSPL- and TMPRSS13-specific primers in the indicated tissues and cells. As a template, Human Multiple Tissue cDNA Panels were used. The expression level of GAPDH mRNA in each sample was used as an internal control. HUVEC; human umbilical vein endothelial cells.](jmgm-03-167-g003){#F3}

The recombinant extracellular regions of human MSPL (hMSPL) and hTMPRSS13 (*i.e.*, SRCR domain and serine protease domain) after transfection of the constructs into HEK 293T cells were purified from the serum-free culture medium and then characterized. The substrate specificities of the recombinant hMSPL are shown in [Table 2](#T2){ref-type="table"}. Among the synthetic substrates tested, hMSPL preferentially hydrolyzes dibasic substrates (R/K at P1 and P2 positions) and furin substrate L-pyroglutamyl-R-T-K-R-4-methylcoumaryl-7-amide (MCA) with R at P1 and P4 being the best. Peptide substrate of HPAI virus A/chick/Penn/1370/83 (H5N2), M-R-N-V-P-Q-K-K-K-R↓-G-L-F-G with K at position P4 is also cleaved by hMSPL efficiently, the activity being equivalent to the furin substrate. However, substrates with Lys at P1 position are less hydrolyzed. Unlike trypsin and plasmin, Bz-R-MCA and Boc-V-L-K-MCA are not hydrolyzed by MSPL and no activity is observed on the substrates for elastase and chymotrypsin-type proteases. Recombinant hTMPRSS13 shows similar substrate specificity to that of hMSPL. The active site mutants, hMSPLS506A and hTMPRSS13S511A, do not hydrolyze any substrates at all. The activity of hMSPL is inhibited by trypsin inhibitors, such as aprotinin, benzamidine and Bowman-Birk trypsin inhibitor, but, unlike trypsin, α~1~-antitrypsin does not inhibit the enzyme activity ([@B14]). In the furin inhibitors tested, decanoyl-RVKR-chloromethylketone, but not α1-antitrypsin Portland, inhibits the enzyme activity with a low *Ki* value of 2.9 nM (Okumura et al, submitted). The inhibitor specificity of recombinant hTMPRSS13 is similar to that of hMSPL.

PROTEOLYTIC ACTIVATION OF HA~0~ OF HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUS BY hMSPL AND hTMPRSS13
=================================================================================================

A large number of HPAI (H5 and H7) viruses has the HA cleavage site sequence of R-K/R-(K/R/X)-R, which is cleavable by furin, PC5/6, hMSPL and hTMPRSS13. On the other hand, part of HPAI viruses has the other cleavage site sequence of K-K/R-(K/R/X)-R with K at P4 position. To analyze the cleavage specificities of hMSPL and hTMPRSS13 against the motifs of HPAI, we performed mass spectrometry analyses of the synthetic HA peptides containing the cleavage motif sequence and part of membrane fusion domain [G-L-F-G]{.ul} sequence at the C-terminal side, M-R-N-V-P-Q-K-K-K-R-[G-L-F-G]{.ul} (A/chicken/Pennsylvania/1370/83(H5N2)), and P-E-P-S-K-K-R-K-K-R-[G-L-F-G]{.ul} (A/FPV/Rostock/34(H7N1)), after incubation with these enzymes for 1 h. Both enzymes preferentially cleaved the C-terminal side of R adjacent to the [G-L-F-G]{.ul} sequence. There was no significant difference in cleavage efficiency by hMSPL and hTMPRSS13 between the peptide M-R-N-V-P-Q-K-K-K-R-[G-L-F-G]{.ul} with K at P4 position and P-E-P-S-K-K-R-K-K-R-[G-L-F-G]{.ul} with R at P4 position (Okumura et al, submitted). Similar results were obtained in the experiments of eight different synthetic peptides with K/R at P4 from HPAI viruses.

For *exo vivo* experiments, we established full-length human MSPL and TMPRSS13 stable transfectant ECV-304 cells, ECV304-MSPL and ECV304-TMPRSS13, respectively. Since recombinant HA expression system of HPAI virus with the K-K-K-R cleavage site is not currently available in spite of various trials, we used in the following experiments the expression of highly virulent influenza A/chick/Penn/1/83 (H5N2) variant 47 ([@B27]) as an example of poor-susceptible strain to furin. This variant has R-K-K-R cleavage motif but poor cleavage susceptibility to furin. After infection of ECV304-MSPL, ECV304-TMPRSS13 cells and wild-type ECV304 (ECV304-WT) cells with the A/chicken/ Penn/1/83 (H5N2) variant 47 HA/SV40 recombinant virus for 48 h, HA cleavage efficiencies and cell fusion activity monitored by giant cell formation were analyzed. The recombinant HA~0~ in ECV304-WT cells was converted to HA~1~ subunit with low efficiency of 9-14%, although higher conversion rates of 37-42% were observed in both ECV304-MSPL and ECV304-TMPRSS13 cells (Okumura et al, submitted). On the other hand, furin-susceptible recombinant H7 HA~0~ with R-K-K-R motif showed 40-45% conversion in WT and MSPL/TMPRSS13-transfectant cells after infection with the A/FPV/Rostock/34 H7 HA/SV40 recombinant virus ([@B28]) under the same experimental conditions. The proteolytically activated recombinant HA~0~ of HPAI viruses facilitated cell fusion. These results suggest that MSPL and TMPRSS13 are novel candidate HA~0~ processing proteases for HPAI viruses, in addition to furin and PC5/6.

UPREGULATION BY INFECTION OF LATENT PANCREATIC TRYPSIN IN VARIOUS ORGANS
========================================================================

Most of the epidemic human IAV are pneumotropic but a few neurotropic strains can multiply both in the airway and brain. In addition, a rare but often fatal encephalopathy caused by infection with a pneumotropic IAV has been reported in children with Reye\'s syndrome and influenza-associated encephalopathy ([@B7]; [@B8]). Recently, we reported that IAV infection can markedly upregulate latent pancreatic trypsin in the brain ([@B23]) and various organs that may have not only a HA~0~ processing activity but also a maturase activity of upregulated proMMP-9 ([@B44]).

[Figure 4](#F4){ref-type="fig"} shows the localization of brain trypsin I determined by *in situ* hybridization. The results showed that this enzyme clusters in the hippocampal pyramidal and dentate gyrus neuronal cells and also distributes in endothelial cells of the brain capillaries, particularly in the allocortex. The enzyme distribution pattern supports the accumulation of neurovirulent IAV WSN(H1N1) antigen in hippocampal neuronal cells ([@B35]) and that of pneumotropic IAV Aichi/2/68(H3N2) antigen in the brain capillaries (Yao et al, 2006). Upregulation of proMMP-9 and its convertase trypsin seems to synergistically enhance the destruction of basement membrane component type IV collagen and endothelial cell tight junction components, resulting in sever edema and connective tissue damage in various organs.

![*In situ* hybridization of trypsin I in rat brain. Low-power photomicrographs of rat brain section, hybridized with rat trypsin I antisense probe (A) and sense probe (B). Bars in A and B represent 1 mm. High power photographs of A show that the positive staining is localized in pyramidal neurons of the cornuammonis (CA)1-2 (C) and CA-3 (D), and in the granular cells of the dentate gyrus (DG) (E). Capillary endothelial cells (En) were also heavily stained (D and F). Bars, C, D and E = 100 μm, F = 50 μm.](jmgm-03-167-g004){#F4}

To provide evidence for the roles of cellular proteases in influenza virus infection, phenotype analyses of trypsin I knockout mouse and TMPRSS13 knockout mouse after influenza virus infection are now under investigations.

###### 

Substrate specificities of recombinant soluble hMSPL

  Substrate (100 μM)             Relative activity (%)
  ------------------------------ -----------------------
  Boc-Q-A-R-MCA                  100.0±1.8
  Pyr-R-T-K-R-MCA                3620.7±21.6
  M-R-N-V-P-Q-K-K-K-R↓-G-L-F-G   3312.1±43.2
  Boc-Q-R-R-MCA                  707.7±5.9
  Boc-R-V-R-R-MCA                667.4±5.2
  Boc-L-R-R-MCA                  350.0±2.3
  Boc-L-K-R-MCA                  192.3±1.9
  Boc-E-K-K-MCA                  57.8±0.8
  Boc-E(OBzl)-A-R-MCA            66.7±1.1
  Boc-L-S-T-R-MCA                46.7±0.3
  Boc-F-S-R-MCA                  33.3±0.2
  Boc-Q-G-R-MCA                  20.0±0.2
  Boc-L-T-R-MCA                  18.9±0.1
  P-F-R-MCA                      12.2±0.1
  Boc-E(OBzl)-G-R-MCA            11.1±0.1
  Boc-V-L-K-MCA                  0.0±0.0
  Bz-R-MCA                       0.0±0.0
  Suc-A-P-A-MCA                  0.0±0.0
  Suc-A-A-P-F-MCA                0.0±0.0

The amidolytic activities of the purified hMSPL were analyzed toward various synthetic peptides in 0.1 M Tris-HCl (pH 8.0) at 37°C. The amount of 7-amino-4-methylcoumarin and the C-terminal fragment peptide liberated from the substrate were determined. One unit of enzyme activity was defined as the amount that degraded 1 μmol of substrate per min. Data are mean ± SD of three separate experiments and are expressed as percentages of activity toward Boc-Q-A-R-MCA.

CONCLUSIONS
===========

Cellular HA~0~ processing enzymes are prerequisite for the infectivity and pathogenicity of human IAV and HPAI viruses. In addition, IAV-induced trypsin and proMMP-9 causes further tissue damage. Anti-influenza virus drugs, inhibitors of viral neuraminidase, are going to be stockpiled in many countries as part of their anti-pandemic planning. However, adverse effects have recently been observed from its therapeutic or prophylactic administration ([@B26]), including reports of increasingly frequent neuraminidase inhibitor resistant virus ([@B18]). To prevent the emergence of drug-resistant mutants and to improve the therapeutic potential of these drugs, the combined use of several anti-viral drugs with different modes of action seems preferable. One promising candidate anti-influenza drug could be inhibitors of cellular processing proteases of viral envelope fusion glycoprotein precursor HA~0~, which inhibit viral entry into cells. The other strategy is inhibition of up-regulation of trypsin and proMMP-9, which might be useful to prevent tissue damage in various organs.
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